Day: June 2, 2021

Adex Mining Announces Senior Management Change

Adex Mining Announces Senior Management Change

TORONTO, June 02, 2021 (GLOBE NEWSWIRE) — Adex Mining Inc. (“Adex” or the “Company”) (TSX‐V: ADE) announces today that the board of directors of the Company has appointed Volodymyr Ivanov as Interim Chief Financial Officer. Mr. Ivanov has over 9 years of corporate accounting and public accounting firm experience in various positions. He is a member of the Certified Public Accountants of Canada and the Association of Chartered Certified Accountants of the United Kingdom. He assumes the role from Olga Balanovskaya, who had served as Chief Financial Officer of the Company since October 2017. The Chief Financial Officer change is effective as of June 1, 2021. The Company wishes to thank Ms. Balanovskaya for her service. ABOUT ADEX Adex Mining Inc. is a Canadian junior mining company with an experienced management...

Continue reading

Bombardier Specialized Aircraft Confirms Deal with U.S. Air Force for up to Six More Global Aircraft in Special Mission Configuration

Bombardier Specialized Aircraft Confirms Deal with U.S. Air Force for up to Six More Global Aircraft in Special Mission Configuration

Global business jets are the backbone of the U.S. Air Force Battlefield Airborne Communications Node (BACN) program, and a go-to platform for special missions around the world BACN aircraft, known in the U.S. Air Force as the E-11A, are developed and modified by Bombardier’s highly skilled engineering teams in Wichita, Kansas Contract, which includes one firm aircraft order, underscores Bombardier’s status as a key U.S. aerospace employer WICHITA, Kansas, June 02, 2021 (GLOBE NEWSWIRE) — Bombardier is pleased to confirm an agreement between its Learjet Inc. subsidiary and the U.S. Air Force in support of the Battlefield Airborne Communications Node (BACN) program. The Indefinite Delivery Indefinite Quantity (IDIQ) contract provides the USAF with flexible ordering and includes an immediate firm order for one Global 6000 aircraft,...

Continue reading

First Busey Corporation Finalizes Acquisition of Cummins-American Corp. and Glenview State Bank

First Busey Corporation Finalizes Acquisition of Cummins-American Corp. and Glenview State Bank

CHAMPAIGN, Ill. and GLENVIEW, Ill., June 02, 2021 (GLOBE NEWSWIRE) — First Busey Corporation (“Busey”) (NASDAQ: BUSE), the holding company for Busey Bank, announced the completion of its acquisition of Cummins-American Corp. (“CAC”), the holding company for Glenview State Bank (“GSB”), effective May 31, 2021.  The transaction was previously announced on January 19, 2021. Under terms of the definitive agreement, each share of CAC common stock issued and outstanding as of the effective date was converted into the right to receive 444.4783 shares of First Busey common stock and $14,173.96 in cash, which cash consideration amount reflects the adjustments made in accordance with the terms of the Merger Agreement.  In addition, as additional merger consideration received by CAC’s shareholders in the Merger, CAC paid a special dividend...

Continue reading

Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Second Quarter Common Stock Distribution of $0.1160 Per Share

Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Second Quarter Common Stock Distribution of $0.1160 Per Share

TORONTO, June 02, 2021 (GLOBE NEWSWIRE) — Sprott Focus Trust, Inc. (Nasdaq-FUND) (the “Fund” or “FUND”) has declared a quarterly distribution of $0.1160 per share on its Common Stock. The distribution, optionally payable in additional shares of Common Stock or in cash by specific stockholder election, is to be paid on June 25, 2021 to stockholders of record at the close of business on June 14, 2021 (ex-dividend on June 11, 2021). The price of shares issued for reinvestment will be determined on June 18, 2021. The Fund currently has adopted a Distribution Policy of paying quarterly distributions on its Common Stock. Distributions are being made at the annual rate of 6% of the rolling average of the prior four calendar quarter-end net asset values (“NAVs”), with the fourth quarter distribution being the greater of 1.50% of the rolling...

Continue reading

Allied Announces Filing of Final Base Shelf Prospectus

Allied Announces Filing of Final Base Shelf Prospectus

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, June 02, 2021 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) announced today that it has filed and obtained receipts for a final base shelf prospectus. The final base shelf prospectus dated June 2, 2021 was filed with the securities regulatory authorities in each of the provinces of Canada. The final base shelf prospectus is valid for a 25-month period, during which time Allied may offer and issue, from time to time, units and debt securities, or any combination thereof, having an aggregate offering price of up to $3.0 billion. The specific terms of any offering of securities will be contained in a shelf prospectus supplement filed at the time of such offering. Allied will no longer...

Continue reading

Liquid Media Provides Corporate Update

Liquid Media Provides Corporate Update

VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: YVR) announced today that it has accepted the resignation of Daniel Cruz from his positions on the Board of Directors of Liquid and its affiliates. The Company wishes to thank Mr. Cruz for his years of dedicated services to the Company’s board, and will continue to work with Mr. Cruz on a consultancy basis going forward. Further to its press release of March 31, 2021, the Company also announces the expiry of its letter of intent with CurrencyWorks Inc. The Company will continue to evaluate and review the possible paths available to it to use blockchain technology and tokenisation (of which NFTs are an element) to provide a novel and durable element of entertainment financing and monetization,...

Continue reading

ORIC Pharmaceuticals Reports Initial Clinical Data Being Presented at ASCO from Phase 1b Trial of ORIC-101 in Combination with Nab-Paclitaxel

ORIC Pharmaceuticals Reports Initial Clinical Data Being Presented at ASCO from Phase 1b Trial of ORIC-101 in Combination with Nab-Paclitaxel

Initial safety data showed combination regimen at the recommended Phase 2 dose was well tolerated; treatment-related adverse events primarily Grade 1 or 2, with no treatment-related discontinuations ORIC-101 plasma concentrations provided excellent target coverage; no evidence of drug-drug interaction with nab-paclitaxel Translational data showed pharmacodynamic modulation of GR biomarkers and high rates of GR expression in tumor types of interest Antitumor activity demonstrated across multiple advanced solid tumors in heavily pretreated patients, including those previously treated with a taxane-based therapy Extended PFS observed in patients with late-line relapsed pancreatic cancer who had previously progressed on or after nab-paclitaxel Conference call and webcast today at 5:00 p.m. ET SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June...

Continue reading

Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency

Wave Life Sciences Announces Proof-of-Concept Preclinical Data for ADAR Editing Program in Alpha-1 Antitrypsin Deficiency

First proof-of-concept in vivo data for RNA editing using endogenous ADAR enzymes in alpha-1 antitrypsin deficiency ADAR editing resulted in therapeutically meaningful restoration of circulating functional AAT protein Wave’s program in alpha-1 antitrypsin deficiency aims to correct the single base mutation in mRNA derived from the SERPINA1 Z allele, thereby addressing both lung and liver manifestations of the disease CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced the first proof-of-concept preclinical data for its ADAR (adenosine deaminases acting on RNA)-mediated RNA editing (“ADAR editing”) program in alpha-1 antitrypsin deficiency (AATD)....

Continue reading

Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

Flexion Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

BURLINGTON, Mass., June 02, 2021 (GLOBE NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference. The virtual fireside chat is scheduled to begin at 3:50 p.m. ET on Tuesday, June 8, 2021. To access the live webcast and subsequent archived recording of the presentation, please visit the Flexion website at http://ir.flexiontherapeutics.com. About Flexion TherapeuticsFlexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of people with musculoskeletal conditions, beginning with osteoarthritis, the most common form of arthritis. The Company’s...

Continue reading

Cascade Acquisition Corp. Announces Receipt of Notice from NYSE Regarding Late Filing of Quarterly Report on Form 10-Q

Cascade Acquisition Corp. Announces Receipt of Notice from NYSE Regarding Late Filing of Quarterly Report on Form 10-Q

New York, NY, June 02, 2021 (GLOBE NEWSWIRE) — Cascade Acquisition Corp. (NYSE: CAS) (the “Company”) today announced that it has received a notice (“Notice”) from the NYSE Regulation staff of the New York Stock Exchange (the “NYSE”) as a result of its failure to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 (the “Form 10-Q”) in a timely fashion. The Notice advised the Company that it was not in compliance with the NYSE’s continued listing requirements under the timely filing criteria established in Section 1007 of the NYSE Company Guide. As reported by the Company in its Form 12b-25 filed with the Securities and Exchange Commission (the “SEC”) on May 17, 2021, the Company was unable to file its Form 10-Q within the prescribed time period without unreasonable effort or...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.